ACLS Provider: Course

Incorrect. Ventilations are delivered at a rate of 6-8 breaths per minute to prevent hyperventilation.

Incorrect. Adenosine is administered at 0.1 mg/kg as a rapid IV push for terminating narrow-complex SVT caused by reentrant pathways.

Incorrect. Atropine blocks vagal stimulation, increasing heart rate in cases of symptomatic bradycardia.

Incorrect. PEA is treated with epinephrine and high-quality CPR to address underlying reversible causes.

Incorrect. Asystole is a non-shockable rhythm requiring immediate CPR and epinephrine administration.

Incorrect. A supine position ensures proper electrode placement and effective delivery of defibrillation shocks.

Incorrect. TTM is used to reduce neurological injury post-ROSC by maintaining a core temperature of 32-36°C.

Incorrect. Compressing to one-third the depth of the chest ensures adequate perfusion while minimizing the risk of injury.

Incorrect. The correct compression-to-ventilation ratio for adult CPR without an advanced airway is 30:2.

Incorrect. The jaw thrust maneuver opens the airway without moving the cervical spine, reducing the risk of spinal injury.

Incorrect. Maintaining this range prevents hypoxia while minimizing the risks of hyperoxia and oxidative injury.

Incorrect. IV access is preferred for rapid administration; IO is the alternative if IV access is unavailable.

Incorrect. Naloxone reverses opioid-induced respiratory depression, restoring normal respiratory function.

Incorrect. The jaw thrust maneuver opens the airway without manipulating the cervical spine, protecting against spinal cord injury.

Incorrect. Epinephrine is given first in VF during cardiac arrest, followed by amiodarone as an antiarrhythmic after defibrillation attempts.

Incorrect. Pulseless VT is treated with defibrillation, not atropine. Atropine is used for symptomatic bradycardia.

Incorrect. Pediatric defibrillation starts at 2 J/kg, increasing to 4 J/kg for subsequent shocks if needed.

Incorrect. Synchronized cardioversion is indicated for unstable atrial fibrillation to restore sinus rhythm and prevent hemodynamic collapse.

Incorrect. Naloxone is used to reverse opioid overdose, restoring respiratory effort in patients with respiratory depression.

Incorrect. For biphasic defibrillators, 120-200 J is the recommended energy range for VF.

Incorrect. Magnesium sulfate is administered to stabilize the myocardium and treat torsades de pointes effectively.

Incorrect. Ventricular fibrillation is the most common cause of sudden cardiac arrest and requires immediate defibrillation.

Incorrect. Oxygen levels should be monitored and optimized to maintain saturation within the target range of 92-96%.

Incorrect. Vagal maneuvers stimulate the vagus nerve, often terminating narrow-complex SVT caused by reentrant circuits.

Incorrect. Magnesium sulfate stabilizes the myocardium and is the drug of choice for torsades de pointes.

Incorrect. Epinephrine is administered after defibrillation to enhance coronary and cerebral perfusion during resuscitation.

Incorrect. Maintains vasoconstriction, improving blood flow to vital organs during resuscitation.

Incorrect. Epinephrine at 0.01 mg/kg is administered every 3-5 minutes during pediatric cardiac arrest to improve coronary perfusion.

Incorrect. Magnesium sulfate is administered to stabilize the myocardium and terminate torsades de pointes.

Incorrect. The two-thumb encircling technique provides high-quality compressions for infants during CPR.

Incorrect. Rhythm checks should be performed every 2 minutes, coinciding with rescuer role switches, to evaluate for shockable rhythms.

Incorrect. CPR is the primary intervention for PEA, followed by epinephrine and identification of reversible causes.

Incorrect. The correct dose of epinephrine for pediatric cardiac arrest is 0.01 mg/kg IV/IO, not 1 mg/kg.

Incorrect. Epinephrine is administered every 3-5 minutes during pediatric cardiac arrest to enhance coronary and cerebral perfusion.

Incorrect. Adenosine is used for narrow-complex SVT, not wide-complex tachycardia, which is typically treated with amiodarone.

Incorrect. Providing 6-8 breaths per minute prevents hyperventilation and maintains adequate oxygenation during CPR with an advanced airway.

Incorrect. Pulseless VT is treated with defibrillation, while synchronized cardioversion is reserved for tachyarrhythmias with a pulse.

Incorrect. Defibrillation is the priority for VF and should not be delayed for drug administration, as it is the definitive treatment.

Incorrect. Chest compressions should be paused for less than 10 seconds to minimize interruptions during CPR when delivering a shock.

Incorrect. Placing hands on the lower half of the sternum ensures effective chest compressions without damaging other structures.

Incorrect. Providing 6-8 breaths per minute ensures adequate oxygenation and ventilation without interfering with chest compressions.

Incorrect. A rate of 100-120 compressions per minute ensures adequate circulation in pediatric patients.

Incorrect. The jaw thrust technique opens the airway while minimizing cervical spine movement, reducing the risk of further injury.

Incorrect. Stabilizes the myocardium and suppresses arrhythmias during refractory VF or pulseless VT.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and should be addressed during resuscitation efforts.

Incorrect. Magnesium sulfate stabilizes cardiac myocytes and is the drug of choice for treating torsades de pointes.

Incorrect. High-quality CPR is the primary treatment for asystole, along with epinephrine and addressing reversible causes.

Incorrect. Rhythm checks are performed every 2 minutes during pauses in CPR to evaluate for shockable rhythms.

Incorrect. Asystole is a non-shockable rhythm requiring immediate high-quality CPR and epinephrine to optimize perfusion.

Incorrect. Early stabilization of blood pressure and oxygenation is critical to preventing further cardiac arrest after ROSC.

Incorrect. Epinephrine at 1 mg IV every 3-5 minutes is used to enhance perfusion during cardiac arrest.

Incorrect. A compression fraction above 80% ensures that most of the resuscitation time is spent performing chest compressions.

Incorrect. Immediate defibrillation is critical for shockable rhythms like ventricular fibrillation and pulseless VT.

Incorrect. Ventricular fibrillation presents as a disorganized rhythm that requires immediate defibrillation.

Incorrect. Administered every 3-5 minutes to restore circulation by increasing coronary and cerebral perfusion pressure.

Incorrect. Chest compressions are performed to dislodge the obstruction and restore effective ventilation in an unresponsive infant.

Incorrect. Atropine at 0.5 mg IV is the first-line treatment for symptomatic bradycardia caused by vagal stimulation.

Incorrect. Atropine is the first-line drug for symptomatic bradycardia, increasing heart rate by blocking vagal stimulation.

Incorrect. Asystole is a non-shockable rhythm treated with high-quality CPR and epinephrine.

Incorrect. Post-ROSC care focuses on stabilizing ventilation and oxygenation to prevent hypoxia or hyperoxia.

Incorrect. ROSC stands for "Return of Spontaneous Circulation," indicating the resumption of a perfusing rhythm.

Incorrect. Hypokalemia can cause cardiac arrhythmias and is included in the "H's" of reversible causes of cardiac arrest.

Incorrect. The target oxygen saturation is 92-96% to avoid hyperoxia, which can contribute to oxidative injury.

Incorrect. Synchronized cardioversion is used for unstable atrial fibrillation to restore organized electrical activity.

Incorrect. Asystole is not a shockable rhythm; it is treated with high-quality CPR and epinephrine.